Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy-A Feasibility Study.

Magnetic resonance imaging Magnetic resonance imaging–derived printed prostate model Patient-tailored prostatectomy Prostate cancer Radical prostatectomy Three-dimensional model

Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
06 2022
Historique:
received: 27 05 2020
revised: 22 07 2020
accepted: 10 08 2020
pubmed: 3 9 2020
medline: 9 6 2022
entrez: 3 9 2020
Statut: ppublish

Résumé

In this prospective single-center feasibility study, we demonstrate that the use of three-dimensional (3D)-printed prostate models support nerve-sparing radical prostatectomy (RP) and intraoperative frozen sectioning (IFS) in ten men suffering from intermediate- and high-risk prostate cancer (PC), of whom seven harbored pT3 disease. Patient-specific 3D resin models were printed based on preoperative multiparametric magnetic resonance imaging (mpMRI) to provide an exact 3D impression of significant tumor lesions. RP and IFS were planned in a patient-tailored fashion. The 36-region Prostate Imaging Reporting and Data System (PI-RADS) v2.0 scheme was used to compare the MRI/3D print with whole-mount histopathology. In all cases, localization of the index lesion was correctly displayed by MRI and the 3D model. Localization of significant PC lesions correlated significantly (Pearson`s correlation coefficient of 0.88; p <  0.001). In addition, a significant correlation of the width, length, and volume of the tumor and prostate gland, derived from the printed model and histopathology, was found, using Pearson's correlation analyses and Bland-Altman plots. In conclusion, 3D-printed prostate models correlate well with final pathology and can be used to tailor RP. PATIENT SUMMARY: The use of three-dimensional (3D)-printed prostate models based on preoperative magnetic resonance imaging (MRI) may improve prostatectomy outcome. This study confirmed the accuracy of 3D-printed prostates compared with pathology from radical prostatectomy specimens. Thus, MRI-derived 3D-printed prostate models can assist in prostate cancer surgery.

Identifiants

pubmed: 32873530
pii: S2588-9311(20)30128-0
doi: 10.1016/j.euo.2020.08.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-361

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Christopher Darr (C)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Friederike Finis (F)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Manuel Wiesenfarth (M)

Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Francesco Giganti (F)

Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK.

Stephan Tschirdewahn (S)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Ulrich Krafft (U)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Claudia Kesch (C)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

David Bonekamp (D)

Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Michael Forsting (M)

German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; Institute of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany.

Axel Wetter (A)

German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; Institute of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany.

Henning Reis (H)

German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; Institute of Pathology, University Hospital Essen, Essen, Germany.

Boris A Hadaschik (BA)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Johannes Haubold (J)

German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; Institute of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany.

Jan Philipp Radtke (JP)

Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: j.radtke@dkfz-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH